Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» WellPoint says hepatitis C drugs Q1 cost was $50 mln
WellPoint says hepatitis C drugs Q1 cost was $50 mln
WellPoint says hepatitis C drugs Q1 cost was $50 mln
Submitted by
admin
on April 30, 2014 - 1:08pm
Source:
Yahoo/Reuters
News Tags:
hepatitis C
drug costs
Wellpoint
Sovaldi
Gilead Sciences
Headline:
WellPoint says hepatitis C drugs Q1 cost was $50 mln
Do Not Allow Advertisers to Use My Personal information
